Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 2, 1998, Pages 542-549

  Nakae, Jun ^a   Kato, Mikiko ^a   Murashita, Mari ^a   Shinohara, Nozomi ^a   Tajima, Toshihiro ^a   Fujieda, Kenji ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; THYMIDINE;

ARTICLE; AUTOPHOSPHORYLATION; CASE REPORT; CHILD; DRUG EFFECT; FEMALE; GLUCOSE METABOLISM; GROWTH REGULATION; HUMAN; HUMAN CELL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; LEPRECHAUNISM; METABOLISM; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031733512     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.2.4602     Document Type: Article

References (53)

1. Ullrich A, Bell JR, Chen EY, et al. 1985 Human insulin receptor and its relationship to the tyrosine kinase family of oncogene. Nature. 313:756-761.
2. Ebina Y, Ellis L, Jarnagin K, et al. 1985 The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signaling. Cell. 40:747-758.
3. White MF, Kahn CR. 1994 The insulin signaling system. J Biol Chem. 269:1-4.
4. Taylor SI, Cama A, Accili D, et al. 1992 Mutation in the insulin receptor gene. Endocr Rev. 13:566-595.
5. Accili D, Drago J, Lee J, et al. 1996 Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet. 12:106-109.
6. Joshi RV, Lamothe B, Cordonnier N, et al. 1996 Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. EMBO J. 15:1542-1547.
7. Donohue WL, Uchida I. 1954 Leprechaunism: a euphuism for a rare familial disorder. J Pediatr. 45:505-519.
8. Rinderknecht E, Humbel RE. 1978 The amino acid sequence of human insulin-like growth factor 1 and its structural homology with proinsulin. J Biol Chem. 253:2769-2776.
9. Dimitriadis G, Parry Billings M, Bevan S, et al. 1992 Effects of insulin-like growth factor 1 on the rates of glucose transport and utilization in rat skeletal muscle in vitro. Biochem J. 285:269-274.
10. Di Cola G, Cool MH, Accili D. 1997 Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J Clin Invest. 99:2538-2544.
11. Zhao AZ, Zhao H, Teague J, Fujimoto W, Beavo JA. 1997 Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiesterase 3B. Proc Natl Acad Sci USA. 94:3223-3228.
12. Quin JD, Fisher BM, Paterson KR, Inoue A, Beastall GH, MacCuish AC 1990 Acute response to recombinant insulin-like growth factor 1 in a patient with Mendenhall's syndrome. N Engl J Med. 323:1425-1426.
13. Kuzuya H, Matsuura N, Sakamoto M, et al. 1993 Trial of insulin-like growth factor 1 therapy for patients with extreme insulin resistance syndromes. Diabetes. 42:696-705.
14. Schoenle EJ, Zenobi PD, Torresani T, Werder EA, Zachmann M, Froesch ER. 1991 Recombinant human insulin-like growth factor 1 (rh IGF-I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia. 34:675-679.
15. Longo N, Singh R, Griffin LD, Langley SD, Parks JS, Elsas LJ. 1994 Impaired growth in Rabson-Mendenhall syndrome: lack of effect of growth hormone and insulin-like growth factor-1. J Clin Endocrinol Metab. 79:799-805.
16. Backeljauw PF, Alves C, Eidson M, Cleveland W, Underwood LE, Davenport ML. 1994 Effects of intravenous insulin-like growth factor 1 in two patients with leprechaunism. Pediatr Res. 36:749-754.
17. Takahashi Y, Kadowaki H, Momomura K, et al. 1997 A homozygous kinase-defective mutation in the insulin receptor gene in a patient with leprechaunism. Diabetologia. 40:412-420.
18. Nakae J, Morioka H, Ohtsuka E, Fujieda K. 1995 Replacements of Leucine 87 in human insulin receptor alter affinity for insulin. J Biol Chem. 270:22017-22022.
19. Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H. 1983 Assessment of skeletal maturity and prediction of adult height (TW2 method). London: Academic Press.
20. Rosenfeld RG, Doller LA. 1982 Characterization of the somatomedin-C/ insulin-like growth factor 1 (SM-C/IGF-I) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by SM-C/IGF-I and insulin. J Clin Endocrinol Metab. 55:434-440.
21. Conover CA, Rosenfeld RG, Hintz RL. 1986 Hormonal control of the replication of human fetal fibroblasts: role of somatomedin-C/insulin-like growth factor 1. J Cell Physiol. 128:47-54.
22. Taylor SI, Samuels B, Roth J, 1982 Decreased insulin binding in cultured lymphocytes from two patients with extreme insulin resistance. J Clin Endocrinol Metab. 54:919-930.
23. Laemlli UK. 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
24. Livneh E, Prywes R, Kashles O, et al. 1986 Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells. J Biol Chem. 261:12490-12497.
25. 996. J Biol Chem. 265:14777-14783.
26. Winter RJ, Phillips LS, Klein MN, Traisman HS, Green OC. 1979 Somatomedin activity and diabetic control in children with insulin-dependent diabetes. Diabetes. 28:952-954.
27. Amiel SA, Sherwin RS, Hintz RL, Gretner JM, Press CM, Tamborlane WV. 1984 Effect of diabetes and its control on insulin-like growth factors in the young subject with type 1 diabetes. Diabetes. 33:1175-1179.
28. Lanes R, Recker B, Fort P, Lifshitz F. 1985 Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus. Diabetes. 34:156-160.
29. Bereket A, Lang CH, Blethen SL, et al. 1995 Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 80:1312-1317.
30. Daughaday WH, Phillips LS, Mueller MC. 1976 The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver. Endocrinology. 98:1214-1219.
31. Maes M, Underwood LE, Ketelslegers JM. 1986 Low serum somatomedin-C in insulin-dependent diabetes: evidence for a postreceptor mechanism. Endocrinology. 118:377-382.
32. Phillips LS, Goldstein S, Pao C-I. 1991 Nutrition and somatomedin. XXVI. Molecular regulation of IGF-I by insulin in cultured rat hepatocytes. Diabetes. 40:1525-1530.
33. Baxter RC, Bryson JM, Turtle JR. 1980 Somatogenic receptors of rat liver: regulation by insulin. Endocrinology. 107:1176-1181.
34. Zapf J, Waldvogel M, Froesch ER. 1975 Binding of nonsuppressible insulin like activity to human serum. Evidence for a carrier protein. Arch Biochem Biophys. 168:638-645.
35. Hintz RL, Liu F. 1977 Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab. 45:988-994.
36. Martin JL, Baxter RC. 1986 Insulin-like growth factor-binding protein from human plasma: purification and characterization. J Biol Chem. 261:8754-8760.
37. Hasegawa Y, Hasegawa T, Aso T, et al. 1992 Usefulness and limitation of measurement of insulin-like growth factor binding protein-3 (IGFBP-3) for diagnosis of growth hormone deficiency. Endocrinol Jpn. 39:585-591.
38. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Ziesel HJ, Bierich JR. 1990 A specific radioimmunoassay for the growth hormone dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab. 70:1292-1298.
39. Baxter RC, Martin JL. 1986 Radioimmunoassay of growth hormone dependent insulin-like growth factor binding protein in human plasma. J Clin Invest. 78:1504-1512.
40. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR. 1993 Use of insulin-like growth facter-binding protein-2 (IGFBP-2) IGFBP-3, and 1GF-I for assesing growth hormone status in short children. J Clin Endocrinol Metab. 77:1294-1299.
41. Luo J, Murphy LJ. 1992 Differential expression of the insulin-like growth factor binding proteins in spontaneously diabetic rats. J Mol Endocrinol. 8:155-163.
42. Villafuerte BC, Zhang WN, Phillips LS. 1996 Insulin and insulin-like growth factor-1 regulate hepatic insulin-like growth factor binding protein-3 by different mechanisms. Mol Endocrinol. 10:622-630.
43. Zapf J, Hauri C, Waldvogel M, et al. 1989 Recombinant human insulin-like growth factor 1 induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc Natl Acad Sci USA. 86:3813-3817.
44. Umezawa T, Ohsawa Y, Miura Y, Kato H, Noguchi T. 1991 Effect of protein deprivation in insulin-like growth factor-binding proteins in rats. Br J Nutr. 66:105-116.
45. Gosteli-Peter MA, Winterhalter KH, Schmid C, Froesch ER, Zapf J. 1994 Expression and regulation of insulin-likegrowth factor-1 (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone. Endocrinology. 135:2558-2567.
46. Liu J-P, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993 Mice carrying null mutations of the gene encoding insulin-like growth factor 1 (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:59-72.
47. Baker J, Liu J-P, Robertson EJ, Efstratiadis A. 1993 Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 75:73-82.
48. Snyder DK, Clemmons DR. 1990 Insulin-dependent regulation of insulin-like growth factor-binding protein-1. J Clin Endocrinol Metab. 71:1632-1636.
49. Guler HP, Zapf J Scheiwiller, E Froesch ER. 1988 Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ sie in hypophysectomized rats. Proc Natl Acad Sci USA. 85:4889-4893.
50. Guler HP, Schmid C, Zapf J, Froesch ER. 1989 Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci USA. 86:2868-2872.
51. Mehls O, Irzynjec T, Ritz E, et al. 1993 Effects of rhGH and rhIGF-I on renal growth and morphology. Kidney Int. 44:1251-1258.
52. Backeljaw PF, Underwood LE, GHIS Collaborative Group. 1996 Prolonged treatment with recombinant insulin-like growth factor-1 in children with growth hormone insensitivity syndrome-a clinical research center study. J Clin Endocrinol Metab. 81:3312-3317.
53. Takano K, Hizuka N, Asakawa K, Sukegawa I, Shizume K, Demura H. 1990 Effects of sc administration of recombinant human insulin-like growth factor I (IGF-I) on normal human subjects. Endocrinol Jpn. 37:309-317.